Warning letter
Medisca Inc: warning letter of Nov 25, 2015
FDA warning letter 428290 · New York District Office
Key facts
| Reference number | 428290 |
|---|---|
| Company | Medisca Inc |
| Subject | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Nov 25, 2015 |
| Posted date | Dec 8, 2015 |
| Issuing office | New York District Office |
| Product type | Drugs |
| CFR sections cited | 201.120(b), 201.128 |
| Inspection city | Plattsburgh |
| Inspection ZIP | 12901 |
| Inspection start date | Feb 17, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: